The Woodlands, Texas — November 25, 2025 — Leads & Copy — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will participate in two healthcare conferences in December.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 9:00 a.m. ET.
Lexicon will also participate in the 8th Annual Evercore Healthcare Conference on Thursday, December 4 at 9:10 a.m. ET.
The live events and replays of the presentations can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines. Lexicon scientists have studied nearly 5,000 genes and identified over 100 protein targets through the Genome5000™ program. These targets have therapeutic potential in various diseases.
Lexicon has a pipeline of drug candidates in discovery, clinical, and preclinical development for conditions like heart failure, neuropathic pain, and diabetes.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
Source: Lexicon Pharmaceuticals, Inc.
